Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / heparin-induced thrombocytopenia

heparin-induced thrombocytopenia

Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
0
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
4
Financing history
0 rounds
No dated round yet.
Investors on record
4 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
4
  1. Sep 16, 2026
    heparin-induced thrombocytopenia no longer listed on Healthcap Ix Advisor Ab's portfolio page
  2. Sep 16, 2026
    heparin-induced thrombocytopenia no longer listed on Healthcap VII Advisor Ab's portfolio page
  3. Sep 16, 2026
    heparin-induced thrombocytopenia no longer listed on Healthcap Advisor Ab's portfolio page
  4. Sep 16, 2026
    heparin-induced thrombocytopenia no longer listed on OFP V Advisor Ab's portfolio page
Evidence
12 observations
Every observation on this company